Financials in USD. Standardized financial statements.
A compact view of how SOPHiA GENETICS S.A. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Revenue? | $77.27M | $65.17M | $62.37M | $47.56M | $40.45M | $28.40M | $25.36M |
| Revenue Growth? | +18.6% | +4.5% | +31.1% | +17.6% | +42.4% | +12.0% | 0.0% |
| Cost of Revenue? | $29.46M | $21.24M | $19.46M | $16.31M | $15.23M | $10.71M | $7.53M |
| Gross Profit? | $47.81M | $43.94M | $42.91M | $31.25M | $25.22M | $17.69M | $17.83M |
| Gross Margin? | +61.9% | +67.4% | +68.8% | +65.7% | +62.4% | +62.3% | +70.3% |
| Operating Expenses? | $118.74M | $110.50M | $117.74M | $119.08M | $96.71M | $55.08M | $50.12M |
| Operating Income? | -$70.92M | -$66.57M | -$74.83M | -$87.82M | -$71.49M | -$37.39M | -$32.29M |
| EBITDA? | -$61.40M | -$50.76M | -$69.57M | -$81.38M | -$69.24M | -$37.99M | -$30.74M |
| Income Before Tax | -$78.49M | -$61.27M | -$78.50M | -$87.58M | -$73.51M | -$41.23M | -$33.63M |
| Income Tax Expense | $512,000 | $1.22M | $486,000 | -$136,000 | $168,000 | -$1.89M | $162,000 |
| Net Income? | -$79.00M | -$62.49M | -$78.98M | -$87.45M | -$73.67M | -$39.34M | -$33.79M |
| EPS? | $-1.17 | $-0.95 | $-1.22 | $-1.36 | $-1.33 | $-0.82 | $-0.53 |
| Diluted EPS? | $-1.17 | $-0.95 | $-1.22 | $-1.36 | $-1.33 | $-0.82 | $-0.53 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality